| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Total liabilities and stockholders' equity | $201.3B | $205.8B | $219.0B | $220.0B | $211.6B | $217.0B | $218.5B | $228.2B |
| Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | $71.7B | $71.7B | $71.7B | $71.8B | $71.8B | $71.8B | $71.9B | $71.9B |
| Total stockholders' equity | $67.2B | $65.8B | $65.9B | $68.3B | $65.4B | $65.2B | $62.3B | $65.0B |
| Retained earnings | -$15.8B | -$16.5B | -$20.0B | -$17.8B | -$17.7B | -$19.1B | -$21.3B | -$19.6B |
| Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding | $6.8B | $6.8B | $6.8B | $6.8B | $6.8B | $6.8B | $6.8B | $6.8B |
| Accumulated other comprehensive income (loss) | $4.2B | $3.5B | $7.1B | $7.2B | $4.2B | $5.4B | $4.7B | $5.7B |
| Additional paid-in capital | $272.0M | $286.0M | $275.0M | $229.0M | $226.0M | $240.0M | $242.0M | $168.0M |